Clinical Trials Directory

Trials / Completed

CompletedNCT03137940

A Study on Safety of tDCS One-shot in UCP

A Study on Safety and Feasibility of a Session of Transcranial Electrical Stimulation (tDCS "One-shot") in Children and Young Adults With Unilateral Cerebral Palsy (UCP)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
8 (actual)
Sponsor
IRCCS Fondazione Stella Maris · Academic / Other
Sex
All
Age
10 Years – 28 Years
Healthy volunteers
Not accepted

Summary

The study aims to evaluate the safety and the feasibility of transcranial Direct Current Stimulation (tDCS) session in children and young adults with Unilateral Cerebral Palsy (UCP). Secondarily it aims to test the effects of tDCS (real vs sham) in improving, in very short term, Upper Limb (UL) functions.

Detailed description

Unilateral Cerebral Palsy (UCP) represents the most frequent form of CP; the upper limb (UL) is generally more affected than the lower limb with an impact in "activity" and "participation" areas. The non-invasive brain stimulation techniques (NIBS), such as transcranial Direct Current Stimulation (tDCS), appear able to modulate neuronal plasticity processes even more late in age attracting great interest for their potential fallout in the field of rehabilitation. The effects of tDCS in recovery of motor function has more investigated in adults, while in the pediatric population studies on safety and efficacy are still few and not conclusive. This study aims to evaluate the safety and the feasibility of tDCS session in children and young adults with UCP both in short term and in follow up (up to 24 hrs after the tDCS session). Secondarily it aims to test the effects of tDCS (real vs sham) in improving, in short term, UL functions. For the study 6 children (aged 10-17 years) and 6 young adults (aged 18-28 years) with UCP will be recruited. Each subject receives, randomly, a real session and a sham session of tDCS with BrainStim Stimulator. Before (T0), immediately after (T1) and after 1 hour and half (T2) to each tDCS session (real or sham) heart rate, blood pressure and UL functions will be measured. Moreover the subject fills in an ad hoc questionnaire on safety at T1 and T2 and, on call, at 24 hours after the sessions (T3).

Conditions

Interventions

TypeNameDescription
DEVICEreal tDCSone-shot of real tDCS session (1.5mA; 0.06 mA/cm2 for 20 minutes) with BrainStim Stimulator.
DEVICEsham tDCSone-shot of sham tDCS session (20 minutes) with BrainStim Stimulator.

Timeline

Start date
2017-03-20
Primary completion
2017-10-20
Completion
2017-12-30
First posted
2017-05-03
Last updated
2019-08-08

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03137940. Inclusion in this directory is not an endorsement.